Literature DB >> 11043768

Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP.

A M Brauweiler1, I Tamir, J C Cambier.   

Abstract

The balanced interplay between positive and negative signals pathways emanating from surface receptors has emerged as a common paradigm for regulation of cell function and the immune response. Here, we will review the recent progress in analysis of signaling pathways initiated upon antigen receptor (BCR) aggregation, and co-aggregation with the inhibitory IgG receptor FcgammaRIIB. Particular attention is paid to the function of the inositol 5-phosphatase SHIP and its effector p62i(Dok), a RasGAP adapter protein. SHIP and Dok function in FcgammaRIIB-mediated inhibition as well as in feedback regulation of signals generated through the BCR. These inhibitory molecules may play critical roles in the prevention of immune system hyperactivity and resulting autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043768     DOI: 10.1034/j.1600-065x.2000.00612.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  16 in total

Review 1.  B cell inhibitory receptors and autoimmunity.

Authors:  Nicholas R Pritchard; Kenneth G C Smith
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

Review 2.  The pivotal position of the actin cytoskeleton in the initiation and regulation of B cell receptor activation.

Authors:  Wenxia Song; Chaohong Liu; Arpita Upadhyaya
Journal:  Biochim Biophys Acta       Date:  2013-07-23

3.  Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.

Authors:  Ana V Miletic; Amy N Anzelon-Mills; David M Mills; Sidne A Omori; Irene M Pedersen; Dong-Mi Shin; Jeffrey V Ravetch; Silvia Bolland; Herbert C Morse; Robert C Rickert
Journal:  J Exp Med       Date:  2010-10-18       Impact factor: 14.307

4.  TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor.

Authors:  Aaron J Marshall; Allyson K Krahn; Kewei Ma; Vincent Duronio; Sen Hou
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Authors:  Jennifer L Bishop; Laura M Sly; Gerald Krystal; B Brett Finlay
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

Review 6.  A role for SHIP in stem cell biology and transplantation.

Authors:  William G Kerr
Journal:  Curr Stem Cell Res Ther       Date:  2008-05       Impact factor: 3.828

Review 7.  CD22: an inhibitory enigma.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

8.  Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3.

Authors:  Jeffrey D Robson; Dominique Davidson; André Veillette
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 9.  Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Authors:  Carol T Cady; Jeffrey S Rice; Vanessa L Ott; John C Cambier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  Aberrant antibody affinity selection in SHIP-deficient B cells.

Authors:  Wai-Hang Leung; Tatiana Tarasenko; Zuzana Biesova; Hemanta Kole; Elizabeth R Walsh; Silvia Bolland
Journal:  Eur J Immunol       Date:  2012-12-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.